Pioglitazone News and Research

RSS
Study clarifies association between metformin use and lung cancer risk

Study clarifies association between metformin use and lung cancer risk

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

Takeda expands commercial platform in Israel

Takeda expands commercial platform in Israel

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

NAC amino acid may offer new treatment options for psychiatric disorders

NAC amino acid may offer new treatment options for psychiatric disorders

Study finds that triple therapy corrects two core defects in type 2 diabetes

Study finds that triple therapy corrects two core defects in type 2 diabetes

Drug used to control Type II diabetes can help repair spinal cords of mice suffering from inherited disease

Drug used to control Type II diabetes can help repair spinal cords of mice suffering from inherited disease

IDIBELL signs patent licensing agreement with Minoryx

IDIBELL signs patent licensing agreement with Minoryx

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

FDA grants final approval to Breckenridge’s Pioglitazone Hydrochloride ANDA

FDA grants final approval to Breckenridge’s Pioglitazone Hydrochloride ANDA

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

FDA approves Watson’s generic Actos

FDA approves Watson’s generic Actos

Common diabetes treatment may cause bladder cancer

Common diabetes treatment may cause bladder cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.